ORPIANESI, EMANUELA
 Distribuzione geografica
Continente #
EU - Europa 1070
NA - Nord America 453
AS - Asia 218
OC - Oceania 16
SA - Sud America 6
AF - Africa 3
Totale 1766
Nazione #
GB - Regno Unito 763
US - Stati Uniti d'America 446
CN - Cina 157
IT - Italia 144
DE - Germania 61
RU - Federazione Russa 25
IN - India 18
KR - Corea 18
UA - Ucraina 18
FI - Finlandia 17
AU - Australia 16
SE - Svezia 16
TR - Turchia 14
EU - Europa 7
FR - Francia 7
GR - Grecia 7
JP - Giappone 7
NL - Olanda 7
CA - Canada 6
CL - Cile 3
AR - Argentina 2
BE - Belgio 2
ES - Italia 2
BF - Burkina Faso 1
BR - Brasile 1
CR - Costa Rica 1
EG - Egitto 1
IQ - Iraq 1
RO - Romania 1
SC - Seychelles 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 1773
Città #
Southend 752
Seattle 63
Milan 62
Mountain View 51
Wilmington 44
Princeton 34
Beijing 31
Fairfield 25
Houston 25
Redmond 22
Woodbridge 21
Ashburn 17
Ann Arbor 16
Chandler 16
Dearborn 16
Des Moines 14
Jinan 14
Shenyang 14
Medford 12
Nanjing 11
Sydney 10
Cambridge 9
Changsha 8
Athens 7
Nanchang 7
Sakarya 7
Tianjin 7
Saint Petersburg 6
Guangzhou 5
Hebei 5
Jiaxing 5
Ningbo 5
Zhengzhou 5
Costa Mesa 4
Hangzhou 4
Mumbai 4
Segrate 4
Shanghai 4
Taizhou 4
Tennyson 4
Toronto 4
Cornate D'adda 3
Haikou 3
Lanzhou 3
Silver Spring 3
Ankara 2
Auburn Hills 2
Bergamo 2
Boston 2
Brussels 2
Cincinnati 2
Darmstadt 2
Federal Way 2
Fuzhou 2
Hefei 2
Heidelberg 2
Istanbul 2
Menlo Park 2
Palermo 2
Phoenix 2
Redwood City 2
San Diego 2
Wuhan 2
Xian 2
Ariccia 1
Asti 1
Bari 1
Berlin 1
Bloomsbury 1
Bologna 1
Brasília 1
Brindisi 1
Carmignano 1
Chengdu 1
Clawson 1
Codogno 1
Corridonia 1
Crema 1
Forno 1
Gainesville 1
Gifu 1
Grafing 1
Helsinki 1
Higashi-osaka 1
Kagoshima 1
Kiez 1
La Jolla 1
Leawood 1
Leicester 1
Lubbock 1
Mahé 1
Montreal 1
Munich 1
Napoli 1
Newtonville 1
Novate Milanese 1
Nürnberg 1
Ottawa 1
Piane Crati 1
Ponsacco 1
Totale 1464
Nome #
STUDIO DELLE CITOCHINE E DELLE METALLOPROTEASI NELLA LINFANGIOLEIOMIOMATOSI E NELLA SCLEROSI TUBEROSA 190
Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis 154
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival 137
Human LAM/TSC cells efficiently cause lung nodule formation and alveolar destruction. Pharmacological counteraction by modulation of mTOR activity 132
LAM/TSC CELLS BEARING A TSC2 MUTATION SECRETE CHEMOKINES AND MATRIXMETHALLOPROTEINASES 126
ROSUVASTATIN ACTING AS A DEMETHYLATING AGENT AFFECTS PROLIFERATION OF TSC2-/meth ASM CELLS 125
Characterization of human TSC2 cells derived from a TSC/LAM patient chylous effusion 123
MOTILITY AND INVASIVE PROPERTIES OF LAM/TSC CELLS FROM CHYLOUS OF A LAM/TSC PATIENT 121
Matrix methalloproteinase 2 and 7 are new targets in LAM and TSC-related disorders 113
Tuberin deficiency for an epigenetic modification in LAM cells from chylous of a TSC2 patient 110
Direct and indirect pharmacological regulation of mTOR affects fate of LAM/TSC cells. Epithelial to mesenchymal transition features of LAM/TSC cells 108
LAM/TSC cells cause pulmonary nodule development by endonasal administration in nude mice 107
Development of a cutaneous mouse model of TSC and LAM by injection of human tuberin-deficient cells : effects of chromatin remodelling agents 96
Chromatin remodelling by rosuvastatin normalizes TSC2-/meth cell phenotype through the expression of tuberin 94
Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2-/- smooth muscle cells in mice 79
Role of chemokines in tuberous sclerosis and lymphangioleiomyomatosis 56
Differential modulation of matrix metalloproteinases-2 and-7 in LAM/TSC cells 37
Totale 1908
Categoria #
all - tutte 2211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2211


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018221 0141621 3121 2018 544328
2018/2019251 55341716 430 411 9242324
2019/2020356 5021524 2923 4226 5254525
2020/2021191 1410312 2012 717 355515
2021/2022276 5412159 518 2317 23241561
2022/202331 28300 00 00 0000
Totale 1908